Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Gynatren

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Problem: Alle antimykotischen Therapien bei chronisch rezidivierender Vaginalkandidose (CRVC) sind unbefriedigend, solange es… Expand
1991
1991
  • A. Siboulet
  • Gynakologische Rundschau
  • 1991
  • Corpus ID: 39650418
167 patients suffering from nonspecific bacterial vaginoses were vaccinated in a double-blind, randomized, placebo-controlled… Expand
1989
1989
Sixty one women (age range 20–35 years) treated by Gynatren‐immunopotentialization (three vaccinations every second week) were… Expand
1989
1989
52 infertile women (age range 19-35 years) treated by Gynatren-immunopotentialization (three vaccinations every second week) were… Expand
1984
1984
In three different laboratory studies an attempt was made to elucidate the mechanism of action of the immunotherapeutic Gynatren… Expand
1984
1984
: In view of the high cure rates of Trichomonas vaginitis after vaccination with the immunotherapeutic drug Solco Trichovac… Expand
1984
1984
  • G. Karkut
  • Geburtshilfe und Frauenheilkunde
  • 1984
  • Corpus ID: 8226452
In view of the high cure rates of Trichomonas vaginitis after vaccination with the immunotherapeutic drug Solco Trichovac… Expand
1984
1984
  • G. Karkut
  • Gynakologische Rundschau
  • 1984
  • Corpus ID: 46008526
In an open clinical trial 94 women with recurrent bacterial vaginitis were treated with the immunotherapeutic Gynatren… Expand
1984
1984
  • M. Litschgi
  • Gynakologische Rundschau
  • 1984
  • Corpus ID: 42013426
120 patients with ‘non-specific’ bacterial colpitis were vaccinated with the immunotherapeutic Gynatren/SolcoTrichovac. The… Expand